Copeland Capital Management’s Johnson & Johnson JNJ Stock Holding History

Copeland Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,810	Closed	-$442K	–	277
2026 Q1	$442K	Sell	1,810 -18	-1%	-$4.19K	0.01%	146
2025 Q4	$378K	Hold	1,828	–	–	0.01%	142
2025 Q3	$339K	Hold	1,828	–	–	0.01%	143
2025 Q2	$279K	Hold	1,828	–	–	0.01%	138
2025 Q1	$303K	Hold	1,828	–	–	0.01%	136
2024 Q4	$264K	Hold	1,828	–	–	﹤0.01%	140
2024 Q3	$296K	Hold	1,828	–	–	0.01%	137
2024 Q2	$267K	Hold	1,828	–	–	0.01%	140
2024 Q1	$289K	Sell	1,828 -29	-2%	-$4.62K	0.01%	134
2023 Q4	$291K	Sell	1,857 -98	-5%	-$15K	0.01%	126
2023 Q3	$304K	Hold	1,955	–	–	0.01%	132
2023 Q2	$324K	Hold	1,955	–	–	0.01%	133
2023 Q1	$303K	Hold	1,955	–	–	0.01%	132
2022 Q4	$345K	Hold	1,955	–	–	0.01%	133
2022 Q3	$319K	Hold	1,955	–	–	0.01%	133
2022 Q2	$347K	Hold	1,955	–	–	0.01%	130
2022 Q1	$346K	Hold	1,955	–	–	0.01%	128
2021 Q4	$334K	Hold	1,955	–	–	0.01%	131
2021 Q3	$316K	Hold	1,955	–	–	0.01%	132
2021 Q2	$322K	Hold	1,955	–	–	0.01%	131
2021 Q1	$321K	Buy	1,955 +4	+0.2%	+$647	0.01%	133
2020 Q4	$307K	Hold	1,951	–	–	0.01%	129
2020 Q3	$290K	Hold	1,951	–	–	0.01%	119
2020 Q2	$274K	Hold	1,951	–	–	0.01%	119
2020 Q1	$256K	Hold	1,951	–	–	0.02%	120
2019 Q4	$285K	Hold	1,951	–	–	0.01%	127
2019 Q3	$252K	Sell	1,951 -165	-8%	-$21.7K	0.01%	123
2019 Q2	$295K	Sell	2,116 -35	-2%	-$4.84K	0.02%	121
2019 Q1	$301K	Sell	2,151 -600	-22%	-$80.4K	0.02%	124
2018 Q4	$355K	Hold	2,751	–	–	0.03%	122
2018 Q3	$380K	Hold	2,751	–	–	0.02%	132
2018 Q2	$334K	Buy	2,751 +14	+0.5%	+$1.75K	0.02%	130
2018 Q1	$351K	Sell	2,737 -225	-8%	-$30.4K	0.02%	126
2017 Q4	$414K	Hold	2,962	–	–	0.03%	134
2017 Q3	$385K	Sell	2,962 -35	-1%	-$4.64K	0.03%	129
2017 Q2	$396K	Hold	2,997	–	–	0.03%	121
2017 Q1	$371K	Hold	2,997	–	–	0.03%	122
2016 Q4	$345K	Sell	2,997 -450	-13%	-$52K	0.02%	132
2016 Q3	$407K	Sell	3,447 -225	-6%	-$27.3K	0.03%	152
2016 Q2	$445K	Hold	3,672	–	–	0.03%	144
2016 Q1	$397K	Hold	3,672	–	–	0.03%	137
2015 Q4	$377K	Hold	3,672	–	–	0.02%	157
2015 Q3	$343K	Hold	3,672	–	–	0.02%	143
2015 Q2	$358K	Sell	3,672 -1,250	-25%	-$125K	0.02%	177
2015 Q1	$495K	Sell	4,922 -70	-1%	-$7.12K	0.03%	174
2014 Q4	$522K	Sell	4,992 -1,450	-23%	-$153K	0.04%	144
2014 Q3	$687K	Sell	6,442 -422	-6%	-$43.8K	0.07%	106
2014 Q2	$718K	Hold	6,864	–	–	0.08%	90
2014 Q1	$674K	Sell	6,864 -3,500	-34%	-$324K	0.08%	90
2013 Q4	$949K	Sell	10,364 -78	-0.7%	-$7.19K	0.12%	74
2013 Q3	$905K	Hold	10,442	–	–	0.14%	69
2013 Q2	$897K	Buy	+10,442	New	+$886K	0.16%	67

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Copeland Capital Management's JNJ Position: Q2 2026 in Review

Copeland Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,810 shares — an estimated $442K sold.

Copeland Capital Management first reported a position in JNJ in Q2 2013 and held it in 52 quarters. The position peaked at $949K in Q4 2013. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Copeland Capital Management reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Copeland Capital Management sold 1,810 Johnson & Johnson shares in Q2 2026, an estimated $442K.
Copeland Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 52 quarters.
Copeland Capital Management's Johnson & Johnson position peaked at $949K in Q4 2013.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Copeland Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.